Baixar PDF

Outros usuários também visualizaram estes artigos

HFE hemochromatosis: an overview about therapeutic recommendations Rodolfo D. Cancado; Aline Morgan Alvarenga; Paulo Caleb JL Santos;
Hematol Transfus Cell Ther. 2022;44:95-9
Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study Eduardo Cerello Chapchap; Murilo Marques Almeida Silva; Reijane Alves de Assis; Lucila Nassif Kerbauy; Michelli da Silva Diniz; Laércio Alberto Rosemberg; Sandra Regina Loggetto; Aderson da Silva Araujo; Antonio Fabron Junior; Monica Pinheiro de Almeida Verissimo; Giorgio Roberto Baldanzi; Breno Pannia Esposito; Fernando Tricta; Merula Emmanoel Anargyrou Steagall; Claudia Ângela Galleni Di Sessa Vellozo; Kleber Yotsumoto Fertrin; Ronaldo Hueb Baroni; Nelson Hamerschlak;
Hematol Transfus Cell Ther. 2023;45:7-15
Fluvastatin suppresses hemin-induced cell death, reactive oxygen species generation, and elevated labile iron pool Shion Imoto; Katsuyasu Saigo; Mari Kono; Ayako Ohbuchi; Tohru Sawamura; Yuji Mizokoshi; Takashi Suzuki;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S284-90